About Frontier Diagnostics
Every cancer is unique, your care should be too.
Who Are We
Our mission is to advance cancer care by providing precise and reliable diagnostic tools that enable personalised treatment strategies. We provide cutting-edge technology, empowering healthcare providers to make informed decisions and tailor therapies to individual patients.
With a team of passionate scientists, medical professionals, and industry experts, we strive to push the boundaries of cancer diagnostics. We are driven by the belief that early and accurate diagnosis leads to more effective treatments, improved survival rates, and enhanced quality of life for cancer patients.
We understand the challenges cancer presents and are here to provide the guidance and assistance you need. Our mission is to break away from the constraints of a one-size-fits-all approach and offer personalised solutions that align with your individual needs.
At Frontier Diagnostics, we are proud to be at the forefront of advancing cancer diagnostics. Join us in our mission to make a meaningful impact on patient’s lives and transform how cancer is diagnosed and treated.
Meet our Team
We are here to help at every stage of your battle with cancer.
Dr Martin Burow
Bio-Chemist-Former Head of Asia Pacific for Thermo Fisher, and the Founder of DMB Diagnostics. With 30 years of extensive knowledge in the field of medical-, oncology- and circulating tumour cell-diagnostics (CTCs).
Dr Chris Lee
Snr. Pharma with experience in Global Clinical Development and Medical Affairs. Includes leading global teams in developing Global Medical plans, exp. in Phase II/III clinical trials & product pre-launch activities.
Dr Zainab Rai
Distinguished general surgeon in Hepato-Pancreatic-Biliary (HPB) diseases, awarded a prestigious research fellowship from Royal College of Surgeons of England, focusing on advancing treatments for pancreatic cancer.
James Simpson
Graduating with a degree in Biochemistry, beginning his career at a firm of Chartered Accountants. He went on to work at Merrill Lynch and Prudential Bache for institutional private clients, in investment management.
Hamish MacDonald
Led £10m public appeal for Leeds Teaching Hospitals Charitable Foundation, raising £63m. Established robotic surgery, built £20m Molecular Research Building, and enhanced Leeds cancer services with two Research Linear Accelerators.
Iain Richardson
Founder of NFH, Frontier Botanics and emerald mining company Hexa Resources. An experienced deal maker and operator, across a range of industries in finance, natural resources, film and media.